Content about Diabetes

February 1, 2012
Lilly Diabetes donates diabetes camp scholarships

Through a collaboration with the American Diabetes Association, the diabetes division of drug maker Eli Lilly has committed to send 89 children to diabetes camp this summer.

INDIANAPOLIS and ALEXANDRIA, Va. — Through a collaboration with the American Diabetes Association, the diabetes division of drug maker Eli Lilly has committed to send 89 children to diabetes camp this summer.

Lilly Diabetes said it donated the camp scholarships — a fund totaling $89,000 — to the American Diabetes Association's 2012 camp scholarship fund. More than 400 diabetes camping programs exist worldwide serving approximately 30,000 youth with diabetes and their families, Lilly Diabetes said.

February 1, 2012
Study: In Type 2 diabetics not on insulin, self-monitoring has no impact on disease

Self-monitoring blood glucose levels in Type 2 diabetics not on an insulin regimen may contribute little to managing the disease, according to an analysis published online last month by The Cochran Library.

CHICHESTER, England — Self-monitoring blood glucose levels in Type 2 diabetics not on an insulin regimen may contribute little to managing the disease, according to an analysis published online last month by The Cochran Library.

February 1, 2012
Study: Link between diabetes drugs, pancreatic cancer risk unclear

A new study published in the American Journal of Gastroenterology examined the possible link between pancreatic cancer and drugs designed to treat diabetes, and found the association to be unclear.

NEW YORK — A new study published in the American Journal of Gastroenterology examined the possible link between pancreatic cancer and drugs designed to treat diabetes, and found the association to be unclear.

Researchers conducted a case-control study based on the British-based General Practice Research Database, which included drug prescriptions, diagnostics, hospitalizations and fatality information. The researchers also took into consideration such factors as body mass index, smoking, alcohol consumption and diabetes duration.

February 1, 2012
Women with diabetes may be at risk for hearing loss, research finds

Female diabetes patients may experience a greater degree of hearing loss as they get older, particularly if their condition is not well-controlled by medication, according to a new study conducted at Henry Ford Hospital in Detroit.

DETROIT — Female diabetes patients may experience a greater degree of hearing loss as they get older, particularly if their condition is not well-controlled by medication, according to a new study conducted at Henry Ford Hospital in Detroit.

January 31, 2012
FDA approves Lilly-Boehringer Ingelheim diabetes drug

The Food and Drug Administration has approved a new treatment for Type 2 diabetes made by Eli Lilly and Boehringer Ingelheim, the drug makers said.

INDIANAPOLIS — The Food and Drug Administration has approved a new treatment for Type 2 diabetes made by Eli Lilly and Boehringer Ingelheim, the drug makers said.

The FDA approved Jentadueto (linagliptin and metformin) tablets, designed to be taken twice daily. The approval marks the second since the two companies announced their collaboration to develop diabetes drugs in January 2011; the first drug approved under the Lilly-BI partnership was Tradjenta (linagliptin), approved in May 2011.

January 30, 2012
Actavis partners with Poland's Bioton to develop insulin products

Iceland-based drug maker Actavis and Poland-based Bioton have formed a partnership that they said would "shake up" the diabetes market.

WARSAW, Poland — Iceland-based drug maker Actavis and Poland-based Bioton have formed a partnership that they said would "shake up" the diabetes market.

Actavis and Bioton announced the signing of a $73.3 million deal to develop, manufacture and commercialize insulin products, including insulin analogues. Of that, Actavis will pay $29.4 million to Bioton when the deal is signed, while the rest will consist of milestone payments.

January 30, 2012
FDA approves Bydureon

The Food and Drug Administration has approved a long-acting injected diabetes drug made by Amylin Pharmaceuticals and Alkermes, the two companies said.

SAN DIEGO — The Food and Drug Administration has approved a long-acting injected diabetes drug made by Amylin Pharmaceuticals and Alkermes, the two companies said.

The FDA approved Bydureon (exenatide), which the companies called the first once-weekly treatment for Type 2 diabetes. The drug will become available in February.

January 27, 2012
Pharmacy retailers can help bring diabetic limb amputations down through education, MTM

Lower-limb amputation is a very real risk for many of the 25.8 million Americans living with diabetes. Though this study may be encouraging, the job of reducing the incidence of diabetes — and in particular, educating people about the need to watch their diets, take their medications and take care of their bodies — remains far from complete, as other recent stories in the media have revealed.

WHAT IT MEANS AND WHY IT'S IMPORTANT — Lower-limb amputation is a very real risk for many of the 25.8 million Americans living with diabetes. Though this study may be encouraging, the job of reducing the incidence of diabetes — and in particular, educating people about the need to watch their diets, take their medications and take care of their bodies — remains far from complete, as other recent stories in the media have revealed.

January 26, 2012
Diabetes supplies segment preps for competitive bidding

Independent pharmacies with a significant business in diabetes supplies will be facing their next big challenge to that business in January 2013 when competitive bidding of durable medical equipment goes into effect for mail order, Chris Smith, director of policy and regulatory affairs for the National Association of Community Pharmacists, told Drug Store News.

Independent pharmacies with a significant business in diabetes supplies will be facing their next big challenge to that business in January 2013 when competitive bidding of durable medical equipment goes into effect for mail order, Chris Smith, director of policy and regulatory affairs for the National Association of Community Pharmacists, told Drug Store News.

January 26, 2012
Walgreens helped raise $1.4 million-plus for JDRF in 2011

Walgreens and the Juvenile Diabetes Research Foundation on Thursday jointly announced that Walgreens' community-based programs helped raise more than $1.4 million in 2011 for JDRF causes.

NEW YORK — Walgreens and the Juvenile Diabetes Research Foundation on Thursday jointly announced that Walgreens' community-based programs helped raise more than $1.4 million in 2011 for JDRF causes. The year marked the 20th anniversary of Walgreens' partnership with JDRF to raise funds for research to put an end to Type 1 diabetes.

January 25, 2012
CDC study reports drop in lower-limb amputations among diabetes patients

Leg and foot amputations among patients diagnosed with diabetes saw a dramatic decline between 1996 and 2008, thanks to improvements in blood-sugar control, foot care and diabetes management, along with declines in cardiovascular disease, according to a new study conducted by the Centers for Disease Control and Prevention.

ATLANTA — Leg and foot amputations among patients diagnosed with diabetes saw a dramatic decline between 1996 and 2008, thanks to improvements in blood-sugar control, foot care and diabetes management, along with declines in cardiovascular disease, according to a new study conducted by the Centers for Disease Control and Prevention.

January 25, 2012
CinSulin launches concentrated cinnamon extract into food, drug, mass

CinSulin, based in Issaquah, Wash., is in the process of launching a cinnamon water extract to help maintain healthy blood-glucose levels for patients with prediabetes or Type 2 diabetes.

ATLANTA — CinSulin, based in Issaquah, Wash., is in the process of launching a cinnamon water extract to help maintain healthy blood-glucose levels for patients with prediabetes or Type 2 diabetes.

The extract contains a concentrated cinnamon extract through a proprietary process that separates the water-soluble components from unwanted fat-soluble components. The result is an extract that is on average 10 times stronger than the average cinnamon supplement, the company stated.

January 25, 2012
Study: Gardasil doesn't cause autoimmune conditions

A human papillomavirus vaccine created by drug maker Merck does not cause autoimmune conditions after young women are inoculated, according to a new Kaiser Permanente study.

PASADENA, Calif. — A human papillomavirus vaccine created by drug maker Merck does not cause autoimmune conditions after young women are inoculated, according to a new Kaiser Permanente study.

January 23, 2012
Novo Nordisk to open Type 1 diabetes research and development center

In an effort to take Type 1 diabetes research to the next level, Novo Nordisk is set to open a research and development center in Seattle.

PRINCETON, N.J. — In an effort to take Type 1 diabetes research to the next level, Novo Nordisk is set to open a research and development center in Seattle.

The center, slated to open this summer, will combine basic research and early proof-of-concept trials under one umbrella, the drug maker said. Additionally, the center will be staffed by approximately 20 researchers who will be supported by corporate functions in the United States and Denmark.

January 20, 2012
Awareness expected 
to benefit diabetes, DME

According to the American Diabetes Association’s latest figures, 79 million Americans have prediabetes, but only 1-out-of-10 knows it. That suggests a terrific upside in the market of diabetes-testing supplies and diabetes-supportive products as more of those Americans become aware of their condition. 


According to the American Diabetes Association’s latest figures, 79 million Americans have prediabetes, but only 1-out-of-10 knows it. That suggests a terrific upside in the market of diabetes-testing supplies and diabetes-supportive products as more of those Americans become aware of their condition. 


January 20, 2012
Study: General sleep disturbance associated with obesity, diabetes, heart disease

People who suffer from sleep disturbances are at major risk for obesity, diabetes and coronary artery disease, according to new research from the Perelman School of Medicine at the University of Pennsylvania.

PHILADELPHIA — People who suffer from sleep disturbances are at major risk for obesity, diabetes and coronary artery disease, according to new research released Thursday from the Perelman School of Medicine at the University of Pennsylvania.

January 19, 2012
Bristol-Myers Squibb, AstraZeneca diabetes drug hits speed bump at FDA

The Food and Drug Administration has declined to approve a drug for Type 2 diabetes made by Bristol-Myers Squibb and AstraZeneca, saying it needs additional clinical data, the companies said Thursday.

PRINCETON, N.J. — The Food and Drug Administration has declined to approve a drug for Type 2 diabetes made by Bristol-Myers Squibb and AstraZeneca, saying it needs additional clinical data, the companies said Thursday.

January 19, 2012
Study: Treating depression, diabetes at the same time may improve symptoms

Patients that are simultaneously treated for Type 2 diabetes and depression are more likely to adhere to their medication and see improvement in their symptoms, compared with those receiving usual primary care, according to a new study.

NEW YORK — Patients that are simultaneously treated for Type 2 diabetes and depression are more likely to adhere to their medication and see improvement in their symptoms, compared with those receiving usual primary care, according to a new study.

January 18, 2012
Academy of Nutrition and Dietetics: Diabetes prevention, management can be aided by healthy diet, regular exercise

The Academy of Nutrition and Dietetics is reminding consumers that the first-line defenses against Type 2 diabetes are a healthy diet and regular exercise, and that these defenses can be aided with the help of a registered dietitian.

CHICAGO — The Academy of Nutrition and Dietetics is reminding consumers that the first-line defenses against Type 2 diabetes are a healthy diet and regular exercise, and that these defenses can be aided with the help of a registered dietitian.

The organization issued a press release following the announcement that celebrity chef Paula Deen had Type 2 diabetes and was working with Novo Nordisk to shed light on the issue.

January 17, 2012
Novo Nordisk partners with Paula Deen in new diabetes initiative

Danish drug maker Novo Nordisk is partnering with cooking show host Paula Deen to launch a campaign to help adults find ways to manage challenges associated with Type 2 diabetes, the company said Tuesday.

PRINCETON, N.J. — Danish drug maker Novo Nordisk is partnering with cooking show host Paula Deen to launch a campaign to help adults find ways to manage challenges associated with Type 2 diabetes, the company said Tuesday.

Deen and her sons, Bobby and Jamie, star in a series of videos as part of the Diabetes in a New Light initiative, in which Deen is sharing her personal diabetes story for the first time.

January 16, 2012
FDA issues alert about sharing of insulin pens

The Food and Drug Administration's latest message to consumers and healthcare professionals seems like a no-brainer: "Insulin pens are not for sharing."

SILVER SPRING, Md. — The Food and Drug Administration's latest message to consumers and healthcare professionals seems like a no-brainer: "Insulin pens are not for sharing."

But the agency said it knew of two undisclosed hospitals that it said had reused the cartridge components of insulin pens in administering insulin to more than 2,000 patients, though the hospitals reportedly changed the pens themselves.

January 13, 2012
MagnaCare partners with Telcare around dissemination of new, wireless meter

MagnaCare, a health plan management company, on Thursday announced its partnership with Telcare on that company's new wireless-enabled blood glucose meter.

NEW YORK — MagnaCare, a health plan management company, on Thursday announced its partnership with Telcare on that company's new wireless-enabled blood glucose meter. Through this partnership, MagnaCare's clients will be among the first in the country to receive the Telcare BGM meter.

January 12, 2012
Roche launches credit card-sized glucose meter

Roche on Wednesday announced it has received clearance from the Food and Drug Administration for its Accu-Chek Nano SmartView blood-glucose monitoring system.

MANNHEIM, Germany — Roche on Wednesday announced it has received clearance from the Food and Drug Administration for its Accu-Chek Nano SmartView blood-glucose monitoring system. The meter is smaller than a standard credit card, employs a large backlit display and does not require any manual coding or code key for enhanced ease of use, the company stated. It also offers improved functions such as customizable test reminders, pre- and postmeal markers and average glucose calculation.

January 11, 2012
Amylin outlines diabetes strategy for 2012

A special focus on its diabetes franchise will define Amylin Pharmaceuticals' corporate strategy, the company's chief executive said at a recent conference sponsored by J.P. Morgan.

SAN DIEGO — A special focus on its diabetes franchise will define Amylin Pharmaceuticals' corporate strategy, the company's chief executive said at a recent conference sponsored by J.P. Morgan.

January 10, 2012
CVS Caremark's Helena Foulkes outlines integrated pharmacy-based program at forum

CVS Caremark's chief healthcare strategy officer on Tuesday outlined how the company's integrated pharmacy-based program for such chronic diseases as diabetes, called Pharmacy Advisor, increased medication adherence rates and physician initiation of prescriptions for concomitant medications to improve patient health.

WASHINGTON — CVS Caremark's chief healthcare strategy officer on Tuesday outlined how the company's integrated pharmacy-based program for such chronic diseases as diabetes, called Pharmacy Advisor, increased medication adherence rates and physician initiation of prescriptions for concomitant medications to improve patient health.